Clinical Trial Update: Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function [Phase 2]

View source ↗

Summary

Phase 2 safety study of botulinum toxin type A in post-stroke patients with upper-limb involvement and reduced lung function; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Stroke

Drugs mentioned

• Botulinum Toxin Type A (Botox) (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Stroke, Muscle Spasticity | Phase 2 | Status: COMPLETED | Results posted: 2011-10-03